Minnesota Psychiatric Society
Find MPS on Facebook!
  • Home
  • About MPS
    • About MPS
    • Strategic Plan
    • MPS Leadership
    • MPS Council Meetings
    • Committees
    • MPS Newsletters >
      • Newsletter Archive
    • Publications
  • Membership
    • Early Career Psychiatrists >
      • Managing a Practice
      • Loan Forgiveness
    • Fellows/Distinguished Fellows
    • Resident-Fellow Member
    • Medical Students
    • Psychiatric Practice
  • Advocacy
    • Advocacy
    • In the Community
  • Events
    • 2025 Spring Meetings >
      • 5-3-25 Handouts
      • 5-3-25 Photos
  • Ads/Classifieds
  • Resources
    • Resources
    • Public Education Brochures
    • National Resources
    • State Resources
    • Psychiatric Practice Management
    • Risk Management Practices
    • PAL CME Documents
  • Foundation
    • MN Mental Health Community Foundation
    • Mission
    • Projects & Scholarships
    • Volunteer Opportunities
  • Contact Us
  • MN Society of Child and Adolescent Psychiatry
  • 10-16-21 Materials
Picture
Minnesota Psychiatric Society Spring Meetings
Saturday, May 3, 2025
7:30am-4-5:00pm Symposium, 5:00-8:00pm Recognition Dinner
​
Courtyard by Marriott Edina Bloomington
4460 W 78th Street Circle, Edina, MN 55435

​Back to the Future: Psychopharmacology

​Come back to the future with your colleagues at our Spring Meeting, where everything old is new again!
Picture

​Educational Objectives
At the end of the educational activity, the learner will be able to:
  • Review and assess novel antipsychotics and monitoring methods in schizophrenia.
  • Describe changes and important updates of clozapine monitoring
  • Name a neuromodulation technique currently being explored for psychosis symptoms.
  • Discuss history and potential challenges associated with ketamine and psilocybin.
  • Describe the uses, outcomes, and differences of opioid agonist therapies for opioid use disorder.
  • Evaluate drug mechanism of action targeting addiction & mood.
  • Assess the development of Lithium in practice today.

​Who should attend?
This educational activity is intended for psychiatrists, primary care physicians, emergency physicians, psychologists, social workers, physician assistants, registered nurses, advance practice nurses, compliance officers and clinic administrators. All mental health professionals and general health professionals are welcome, including students and residents. 
Picture
Overview
The history of medication reaches back to when our ancestors first ingested plants with intent to treat ailments. As William Osler put it, “The desire to take medicine is perhaps the greatest feature which distinguishes man from animals.”
The development of pharmaceuticals owes as much to serendipity as science. Fleming’s 1928 discovery of penicillin from mold is by far the most famous example of such luck (followed up by intellectual pursuit, of course.)
The first antipsychotic, chlorpromazine, started its life in anesthesia. And our old and perpetual friend, Lithium, began its career in gout.
At the MPS Spring Program, we will delve deeply into pharmacology, focusing on medications, old and new. Attendees will learn cutting edge management of our oldest and most effective drugs: clozapine and lithium. We will examine our newest (and first) non-dopaminergic antipsychotic. We will learn new skills to help our patients with one of mankind’s oldest afflictions: addiction. Other exciting topics include treatment of depression and ADHD, and updates on ketamine and psilocybin. Spend the day with MPS to hone your skills with our remarkable psychiatric pharmaceutical toolbox.
Come back to the future with your colleagues at our Spring Meeting, where everything old is new again!
And, to end with another gem from Osler: “Use all new medications while they still work.”
​

Exhibitors
Axsome  -  Bristol Meyer Squibb  -  Intra-Cellular Therapies, Inc.  -  Teva Medical

​Accreditation and Designation Statement

     In support of improving patient care, this activity has been planned and implemented by American Psychiatric Association (APA) and Minnesota Psychiatric Society (MPS). The American Psychiatric Association (APA) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
     The American Psychiatric Association (APA) designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

​Jointly provided by the American Psychiatric Association and the Minnesota Psychiatric Society

Proudly powered by Weebly